Sign In
Buy MEIP
$3.07
+0 (+0%)
At Close: Dec 09, 2025
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Those Who Purchased MEI Pharma (NASDAQ:MEIP) Shares Five Years Ago Have A 81% Loss To Show For It
01:04pm, Friday, 13'th Mar 2020
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
New Covid-19 Cases Increase, 5 Defensive Stocks to Buy
03:03pm, Thursday, 13'th Feb 2020
Here are five defensive stocks that can shield your portfolio as Covid-19 continues to spread, instilling volatility in the stock market.
MEI Pharma Reports Fiscal Second-Quarter 2020 Results and Operational Highlights
09:02pm, Thursday, 06'th Feb 2020
MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its second quarter ended December 31, 2019.
MEI Pharma Q2 EPS $(0.26) Down From $(0.15) YoY, Sales $1.008M Down From $2.048M YoY
12:00am, Thursday, 06'th Feb 2020Enacting Digital Services Tax More Than Just a Waiting Game for Canada
08:41pm, Wednesday, 29'th Jan 2020
Imposing a digital services tax on corporate revenue has a poor track record of hitting the mark, says Jack Mintz.
NEA Management Company, LLC Buys Cloudflare Inc, PhaseBio Pharmaceuticals Inc, MEI Pharma Inc, ...
12:00am, Friday, 24'th Jan 2020New Enterprise Associates 16 Reports 9.8% Active Stake In MEI Pharma
12:00am, Monday, 30'th Dec 2019Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus
11:38pm, Sunday, 29'th Dec 2019
Biotech stocks advanced in the penultimate week of the year, and the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) is on track to end the year with gains in excess of 25%. The previous week saw FD
